<?xml version="1.0" encoding="UTF-8"?>
<jcr:root xmlns:jcr="http://www.jcp.org/jcr/1.0" xmlns:cq="http://www.day.com/jcr/cq/1.0" xmlns:mix="http://www.jcp.org/jcr/mix/1.0" xmlns:nt="http://www.jcp.org/jcr/nt/1.0" xmlns:sling="http://sling.apache.org/jcr/sling/1.0"
          jcr:primaryType="cq:Page">
  <jcr:content
    cq:template="/apps/wcm-io-samples/sample-app/templates/content/content"
    jcr:primaryType="cq:PageContent"
    jcr:title="Olopatadine"
    sling:resourceType="/apps/wcm-io-samples/sample-app/components/content/page/content">
    <content
      jcr:primaryType="nt:unstructured"
      sling:resourceType="wcm-io/wcm/parsys/components/parsys">
      <contentheadline
        jcr:primaryType="nt:unstructured"
        sling:resourceType="wcm-io-samples/sample-app/components/content/common/contentHeadline"
        headline="Olopatadine" />
      <contentrichtext
        jcr:primaryType="nt:unstructured"
        sling:resourceType="wcm-io-samples/sample-app/components/content/common/contentRichText"
        text="&lt;p&gt;{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 462265189
| IUPAC_name = {(11&amp;apos;&amp;apos;Z&amp;apos;&amp;apos;)-11-[3-(dimethylamino)propylidene]-6,11-&amp;lt;br/&amp;gt;dihydrodibenzo[&amp;apos;&amp;apos;b,e&amp;apos;&amp;apos;]oxepin-2-yl}acetic acid
| image = Olopatadine.svg

&amp;lt;!--Clinical data--&amp;gt;
| tradename = Patanol and others
| Drugs.com = {{drugs.com|monograph|olopatadine-hydrochloride}}
| MedlinePlus = a602025
| pregnancy_category = C
| routes_of_administration = [[Eye drops|Ophthalmic]], intranasal, oral

&amp;lt;!--Pharmacokinetic data--&amp;gt;
| elimination_half-life = 3 hours

&amp;lt;!--Identifiers--&amp;gt;
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 113806-05-6
| ATC_prefix = S01
| ATC_suffix = GX09
| ATC_supplemental = {{ATC|R01|AC08}}
| PubChem = 5281071
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
 | DrugBank = DB00768
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4444528
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = D27V6190PM
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D08293
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1189432

&amp;lt;!--Chemical data--&amp;gt;
| C=21 | H=23 | N=1 | O=3
| molecular_weight = 337.412 [[Gram|g]]/[[Mole (unit)|mol]]
| smiles = O=C(O)Cc2ccc1OCc3c(C(\c1c2)=C\CCN(C)C)cccc3
| InChI = 1/C21H23NO3/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24)/b18-8-
| InChIKey = JBIMVDZLSHOPLA-LSCVHKIXBJ
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H23NO3/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24)/b18-8-
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = JBIMVDZLSHOPLA-LSCVHKIXSA-N
}}

&amp;apos;&amp;apos;&amp;apos;Olopatadine hydrochloride&amp;apos;&amp;apos;&amp;apos; is an [[antihistamine]] (as well as [[anticholinergic]] and [[mast cell]] stabilizer), sold as a [[Prescription drug|prescription]] [[eye drop]] (0.2% solution, &amp;apos;&amp;apos;&amp;apos;Pataday&amp;apos;&amp;apos;&amp;apos; (or &amp;apos;&amp;apos;&amp;apos;Patanol S&amp;apos;&amp;apos;&amp;apos; in some countries), manufactured by [[Alcon]]). It is used to treat itching associated with allergic [[conjunctivitis]] (eye [[allergy|allergies]]). Olopatadine hydrochloride 0.1% is sold as &amp;apos;&amp;apos;&amp;apos;Patanol&amp;apos;&amp;apos;&amp;apos; (or &amp;apos;&amp;apos;&amp;apos;Opatanol&amp;apos;&amp;apos;&amp;apos; in some countries). A [[decongestant]] [[nasal spray]] formulation is sold as &amp;apos;&amp;apos;&amp;apos;Patanase&amp;apos;&amp;apos;&amp;apos;, which was approved by the FDA on April 15, 2008.&amp;lt;ref&amp;gt;[http://www.drugs.com/newdrugs/alcon-s-patanase-nasal-approved-fda-nasal-allergy-symptoms-942.html Drugs.com, Alcon&amp;apos;s Patanase Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms]&amp;lt;/ref&amp;gt; It is also available as an oral tablet in Japan under the tradename &amp;apos;&amp;apos;&amp;apos;Allelock&amp;apos;&amp;apos;&amp;apos;, manufactured by Kyowa Hakko Kogyo.&amp;lt;ref name=KYOWA08&amp;gt;{{cite web | author = Kyowa Hakko Kogyo Co., Ltd. | year = 2007 | url = http://www.e-search.ne.jp/~jpr/PDF/KYOWA08.PDF |format=PDF| title = ALLELOCK Tablets 2.5 &amp;amp; ALLELOCK Tablets 5 (English) | accessdate = 2008-08-10}}&amp;lt;/ref&amp;gt;

It should not be used to treat irritation caused by [[contact lenses]]. The usual dose for Patanol is 1 drop in each affected eye 2 times per day, with 6 to 8 hours between doses.

There is potential for Olopatadine as a treatment modality for steroid rebound (red skin syndrome.)
&amp;lt;ref&amp;gt;{{cite web
| author=Tamura T, Matsubara M, Hasegawa K, Ohmori K, Karasawa A.
| year=2005
| url=http://www.ncbi.nlm.nih.gov/pubmed/15649273
| title=Olopatadine hydrochloride suppresses the rebound phenomenon after discontinuation of treatment with a topical steroid in mice with chronic contact hypersensitivity.}}&amp;lt;/ref&amp;gt;

Olopatadine was developed by Kyowa Hakko Kogyo.&amp;lt;ref&amp;gt;{{cite web
| author=Kyowa Hakko Kogyo Co., Ltd.
| year=2002 | title=Company History | work=Company Information
| publisher=Kyowa Hakko Kogyo Co., Ltd. | url=http://www.kyowa-kirin.co.jp/english/company/history/index.html
| accessdate=16 September 2010 }}&amp;lt;/ref&amp;gt;

== [[Adverse drug reaction|Side effects]] ==
Some known side effects include headache (7% of occurence), eye burning and/or stinging (5%), blurred vision, dry eyes, foreign body sensation, [[hyperemia]], [[keratitis]], eyelid [[edema]], [[pruritus]], [[asthenia]], sore throat ([[pharyngitis]]), [[rhinitis]], [[sinusitis]], and taste perversion.

== See also ==
* [[Doxepin]]

== References ==
{{Reflist|2}}

== External links ==
* [http://www.pataday.com Pataday website]
* [http://www.patanase.com Patanase website]
* [http://www.nlm.nih.gov/medlineplus/druginfo/meds/a602025.html Olopatadine Ophthalmic] via [[MedlinePlus]]

{{Nasal preparations}}
{{Cholinergics}}
{{Histaminergics}}
{{Tricyclics}}

[[Category:Oxepines]]
[[Category:Carboxylic acids]]
[[Category:H1 receptor antagonists]]
[[Category:Amines]]&lt;/p&gt;" />
    </content>
  </jcr:content>
</jcr:root>
